Genital Diseases, Female  >>  Altoprev (lovastatin extended-release formulation)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Altoprev (lovastatin extended-release formulation) / AbbVie
NCT00585052: A Phase II Study of Interaction of Lovastatin and Paclitaxel For Patients With Refractory or Relapsed Ovarian Cancer

Terminated
2
11
US
Paclitaxel, Abraxane, Taxol, Lovastatin, Mevacor, Altoprev
University of Iowa
Ovarian Cancer
02/10
06/13

Download Options